Allysta Pharmaceuticals
PrivateLast Round
Series A
Dec 18, 2019
Total Funding Raised
$20.69M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Allysta Pharmaceuticals operates in Healthcare & Life Sciences and is based in Bellevue, Washington. Its latest recorded funding round was a Series A round in December 2019.
Allysta Pharmaceuticals is a biopharmaceutical company that develops first-in-class therapeutic peptides for rare diseases with high unmet needs, such as Duchenne muscular dystrophy and dry eye disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allysta Pharmaceuticals Comparables
Compare Allysta Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Satellos Bioscience Inc. | 76% | |
| Capricor Therapeutics | 74% | |
| Dyne Therapeutics | 71% |
For institutional investors. Book with your work email.
Allysta Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 18, 2019 | ||||
| Convertible Debt | Apr 16, 2019 | ||||
| Accelerator | Feb 22, 2017 |
For institutional investors. Book with your work email.
Allysta Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morningside Ventures | Series A |
| QB3 | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 345% MoM, from 523 to 2.3K.
- Apr 20, 2026
Monthly visitors grew 47% MoM.
For institutional investors. Book with your work email.
Allysta Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Allysta Pharmaceuticals's valuation, stock price, and market status.
Is Allysta Pharmaceuticals a public or private company?
Allysta Pharmaceuticals is a private company.
What is the current stock price of Allysta Pharmaceuticals?
Allysta Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Allysta Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Allysta Pharmaceuticals worth (valuation)?
Valuation information for Allysta Pharmaceuticals is not publicly available.
Can I buy Allysta Pharmaceuticals stock?
Allysta Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Allysta Pharmaceuticals's last funding round?
Allysta Pharmaceuticals's most recent funding round was Series A on December 18, 2019.
Who are the main investors in Allysta Pharmaceuticals?
Key investors in Allysta Pharmaceuticals include Morningside Ventures.
Will Allysta Pharmaceuticals IPO soon?
No public IPO plans have been announced for Allysta Pharmaceuticals.
How can I track Allysta Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Allysta Pharmaceuticals's shares on secondary markets.